{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T14:00:43Z","timestamp":1795096843355,"version":"4.10.2"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81860099"],"award-info":[{"award-number":["No. 81860099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["No. 20202ACBL206009"],"award-info":[{"award-number":["No. 20202ACBL206009"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-04379-x","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T11:55:25Z","timestamp":1767700525000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and validation of a nomogram for predicting distant metastasis and prognosis in elderly T1\u2013T2 pancreatic ductal adenocarcinoma patients"],"prefix":"10.1007","volume":"17","author":[{"given":"Qingting","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiasheng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"4379_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41575-023-00840-w","volume":"21","author":"ZI Hu","year":"2024","unstructured":"Hu ZI, O\u2019Reilly EM. Therapeutic developments in pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2024;21:7\u201324. https:\/\/doi.org\/10.1038\/s41575-023-00840-w.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4379_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin"},{"key":"4379_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.4708","volume":"4","author":"L Rahib","year":"2021","unstructured":"Rahib L, Wehner MR, Matrisian LM, Nead KT. Estimated projection of US cancer incidence and death to 2040. JAMA Netw Open. 2021;4:e214708. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.4708.","journal-title":"JAMA Netw Open"},{"key":"4379_CR4","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, Magliano MP, Maitra A. Pancreatic cancer: advances and challenges. Cell. 2023;186:1729. https:\/\/doi.org\/10.1016\/j.cell.2023.02.014.","journal-title":"Cell"},{"key":"4379_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s11864-021-00895-4","volume":"22","author":"TJ Ettrich","year":"2021","unstructured":"Ettrich TJ, Seufferlein T. Systemic therapy for metastatic pancreatic cancer. Curr Treat Options Oncol. 2021;22:106. https:\/\/doi.org\/10.1007\/s11864-021-00895-4.","journal-title":"Curr Treat Options Oncol"},{"key":"4379_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41392-022-01268-5","volume":"8","author":"C Zhou","year":"2023","unstructured":"Zhou C, Zhu X, Liu N, Dong X, Zhang X, Huang H, et al. B-lymphoid tyrosine kinase-mediated FAM83A phosphorylation elevates pancreatic tumorigenesis through interacting with \u03b2-catenin. Signal Transduct Target Ther. 2023;8:66. https:\/\/doi.org\/10.1038\/s41392-022-01268-5.","journal-title":"Signal Transduct Target Ther"},{"key":"4379_CR7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s11605-019-04464-x","volume":"24","author":"W Kwon","year":"2020","unstructured":"Kwon W, Park T, He J, Higuchi R, Son D, Lee SY, et al. Is the new T1 category as defined in the eighth edition of the AJCC pancreatic cancer staging system an improvement? J Gastrointest Surg. 2020;24:262\u20139. https:\/\/doi.org\/10.1007\/s11605-019-04464-x.","journal-title":"J Gastrointest Surg"},{"key":"4379_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.22","volume":"2","author":"J Kleeff","year":"2016","unstructured":"Kleeff J, Korc M, Apte M, La Vecchia C, Johnson CD, Biankin AV, et al. Pancreatic cancer. Nat Rev Dis Primers. 2016;2:16022. https:\/\/doi.org\/10.1038\/nrdp.2016.22.","journal-title":"Nat Rev Dis Primers"},{"key":"4379_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/gutjnl-2017-314828","volume":"68","author":"L Huang","year":"2019","unstructured":"Huang L, Jansen L, Balavarca Y, Molina-Montes E, Babaei M, van der Geest L, et al. Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations. Gut. 2019;68:130\u20139. https:\/\/doi.org\/10.1136\/gutjnl-2017-314828.","journal-title":"Gut"},{"key":"4379_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/10732748221109991","volume":"29","author":"AM Altman","year":"2022","unstructured":"Altman AM, White MJ, Marmor S, Shukla D, Chang K, Lou E, et al. The addition of chemoradiation to adjuvant chemotherapy is associated with improved survival following upfront surgical resection for pancreatic cancer with nodal metastases. Cancer Control. 2022;29:10732748221109991. https:\/\/doi.org\/10.1177\/10732748221109991.","journal-title":"Cancer Control"},{"key":"4379_CR11","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2147\/CMAR.S145722","volume":"9","author":"L Tao","year":"2017","unstructured":"Tao L, Yuan C, Ma Z, Jiang B, Xiu D. Surgical resection of a primary tumor improves survival of metastatic pancreatic cancer: a population-based study. Cancer Manag Res. 2017;9:471. https:\/\/doi.org\/10.2147\/CMAR.S145722.","journal-title":"Cancer Manag Res."},{"key":"4379_CR12","doi-asserted-by":"publisher","first-page":"18136","DOI":"10.1038\/s41598-024-69126-8","volume":"14","author":"Y Liu","year":"2024","unstructured":"Liu Y, Gao M, Song Y, Wang L. Establishment of a nomogram model for predicting distant metastasis in pancreatic ductal adenocarcinoma: a comparative analysis of different lymph node staging systems based on the SEER database. Sci Rep. 2024;14:18136. https:\/\/doi.org\/10.1038\/s41598-024-69126-8.","journal-title":"Sci Rep"},{"key":"4379_CR13","doi-asserted-by":"publisher","DOI":"10.18632\/aging.202570","volume":"13","author":"T Lianyuan","year":"2021","unstructured":"Lianyuan T, Deyu L, Haibo Y, Yadong D, Guanjing T. Clinical features and prognostic factors of elderly patients with metastatic pancreatic cancer: a population-based study. Aging. 2021;13:7133. https:\/\/doi.org\/10.18632\/aging.202570.","journal-title":"Aging"},{"key":"4379_CR14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00423-019-01810-0","volume":"404","author":"D Ansari","year":"2019","unstructured":"Ansari D, Althini C, Ohlsson H, Andersson R. Early-onset pancreatic cancer: a population-based study using the SEER registry. Langenbecks Arch Surg. 2019;404:565\u201371. https:\/\/doi.org\/10.1007\/s00423-019-01810-0.","journal-title":"Langenbecks Arch Surg"},{"key":"4379_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/MPA.0b013e31825f3af4","volume":"42","author":"S Amin","year":"2013","unstructured":"Amin S, Lucas AL, Frucht H. Evidence for treatment and survival disparities by age in pancreatic adenocarcinoma: a population-based analysis. Pancreas. 2013;42:249. https:\/\/doi.org\/10.1097\/MPA.0b013e31825f3af4.","journal-title":"Pancreas"},{"key":"4379_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-biochem-011116-110806","volume":"85","author":"FU Hartl","year":"2016","unstructured":"Hartl FU. Cellular homeostasis and aging. Annu Rev Biochem. 2016;85:1\u20134. https:\/\/doi.org\/10.1146\/annurev-biochem-011116-110806.","journal-title":"Annu Rev Biochem"},{"key":"4379_CR17","doi-asserted-by":"publisher","first-page":"8146","DOI":"10.3390\/curroncol29110643","volume":"29","author":"W Li","year":"2022","unstructured":"Li W, Wang W, Yao L, Tang Z, Zhai L. Nomogram for predicting distant metastasis of pancreatic ductal adenocarcinoma: a SEER-based population study. Curr Oncol. 2022;29:8146\u201359. https:\/\/doi.org\/10.3390\/curroncol29110643.","journal-title":"Curr Oncol"},{"key":"4379_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-00820-0","volume":"9","author":"Z Tan","year":"2025","unstructured":"Tan Z, Meng Y, Wu Y, Zhen J, He H, Pu Y, et al. The burden and temporal trend of early onset pancreatic cancer based on the GBD 2021. NPJ Precis Oncol. 2025;9:32. https:\/\/doi.org\/10.1038\/s41698-025-00820-0.","journal-title":"NPJ Precis Oncol"},{"key":"4379_CR19","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3748\/wjg.v22.i2.764","volume":"22","author":"O Higuera","year":"2016","unstructured":"Higuera O, Ghanem I, Nasimi R, Prieto I, Koren L, Feliu J. Management of pancreatic cancer in the elderly. World J Gastroenterol. 2016;22:764. https:\/\/doi.org\/10.3748\/wjg.v22.i2.764.","journal-title":"World J Gastroenterol"},{"key":"4379_CR20","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1245\/s10434-017-6025-x","volume":"25","author":"YS Chun","year":"2018","unstructured":"Chun YS, Pawlik TM, Vauthey J-N. 8th edition of the AJCC cancer staging manual: pancreas and hepatobiliary cancers. Ann Surg Oncol. 2018;25:845\u20137. https:\/\/doi.org\/10.1245\/s10434-017-6025-x.","journal-title":"Ann Surg Oncol"},{"key":"4379_CR21","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1245\/s10434-016-5093-7","volume":"23","author":"B Saka","year":"2016","unstructured":"Saka B, Balci S, Basturk O, Bagci P, Postlewait LM, Maithel S, et al. Pancreatic Ductal Adenocarcinoma is spread to the peripancreatic soft tissue in the majority of resected cases, rendering the AJCC T-Stage Protocol (7th Edition) inapplicable and insignificant: a size-based staging system\u00a0(pT1: \u22642, pT2: >2\u2013\u22644, pT3: >4 cm) is more valid and clinically relevant. Ann Surg Oncol. 2016;23:2010\u20138. https:\/\/doi.org\/10.1245\/s10434-016-5093-7.","journal-title":"Ann Surg Oncol"},{"key":"4379_CR22","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16:e173-180. https:\/\/doi.org\/10.1016\/S1470-2045(14)71116-7.","journal-title":"Lancet Oncol"},{"key":"4379_CR23","doi-asserted-by":"publisher","first-page":"912","DOI":"10.5009\/gnl20306","volume":"15","author":"JS Kang","year":"2021","unstructured":"Kang JS, Mok L, Heo JS, Han IW, Shin SH, Yoon Y-S, et al. Development and external validation of survival prediction model for pancreatic cancer using two nationwide databases: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP). Gut Liver. 2021;15:912. https:\/\/doi.org\/10.5009\/gnl20306.","journal-title":"Gut Liver"},{"key":"4379_CR24","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1186\/s12885-023-11181-x","volume":"23","author":"L Zhu","year":"2023","unstructured":"Zhu L, Shen S, Wang H, Zhang G, Yin X, Shi X, et al. A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma. BMC Cancer. 2023;23:790. https:\/\/doi.org\/10.1186\/s12885-023-11181-x.","journal-title":"BMC Cancer"},{"key":"4379_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00261-017-1330-1","volume":"43","author":"NS Gandhi","year":"2018","unstructured":"Gandhi NS, Feldman MK, Le O, Morris-Stiff G. Imaging mimics of pancreatic ductal adenocarcinoma. Abdom Radiol. 2018;43:273\u201384. https:\/\/doi.org\/10.1007\/s00261-017-1330-1.","journal-title":"Abdom Radiol"},{"key":"4379_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"CA Cancer J Clin"},{"key":"4379_CR27","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1200\/JCO.2016.67.1412","volume":"34","author":"DP Sohal","year":"2016","unstructured":"Sohal DP, Mangu PB, Khorana AA, Shah MA, Philip PA, O\u2019Reilly EM, et al. Metastatic pancreatic cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2016;34:2784. https:\/\/doi.org\/10.1200\/JCO.2016.67.1412.","journal-title":"J Clin Oncol"},{"key":"4379_CR28","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.7150\/jca.57768","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Tian M, Zhou Y, Tan F, Liu W, Zhao L, et al. A novel risk-scoring system conducing to chemotherapy decision for patients with pancreatic ductal adenocarcinoma after pancreatectomy. J Cancer. 2021;12:4433\u201342. https:\/\/doi.org\/10.7150\/jca.57768.","journal-title":"J Cancer"},{"key":"4379_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2021.804785","volume":"8","author":"W Shao","year":"2021","unstructured":"Shao W, Lu Z, Xu J, Shi X, Tan T, Xing C, et al. Effects of total pancreatectomy on survival of patients with pancreatic ductal adenocarcinoma: a population-based study. Front Surg. 2021;8:804785. https:\/\/doi.org\/10.3389\/fsurg.2021.804785.","journal-title":"Front Surg"},{"key":"4379_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/MPA.0000000000001486","volume":"49","author":"AK Malik","year":"2020","unstructured":"Malik AK, Lamarca A, Siriwardena AK, O\u2019Reilly D, Deshpande R, Satyadas T, et al. The influence of patients\u2019 age on the outcome of treatment for pancreatic ductal adenocarcinoma. Pancreas. 2020;49:201\u20137. https:\/\/doi.org\/10.1097\/MPA.0000000000001486.","journal-title":"Pancreas"},{"key":"4379_CR31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000517245","volume":"66","author":"HA Jung","year":"2021","unstructured":"Jung HA, Han BR, Kim HY, Kim HJ, Zang DY, Jung JY. Treatment and outcomes of metastatic pancreatic cancer in elderly patients. Chemotherapy. 2021;66:107. https:\/\/doi.org\/10.1159\/000517245.","journal-title":"Chemotherapy"},{"key":"4379_CR32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.it.2015.02.009","volume":"36","author":"A Lasry","year":"2015","unstructured":"Lasry A, Ben-Neriah Y. Senescence-associated inflammatory responses: aging and cancer perspectives. Trends Immunol. 2015;36:217\u201328. https:\/\/doi.org\/10.1016\/j.it.2015.02.009.","journal-title":"Trends Immunol"},{"key":"4379_CR33","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2009.41.4.187","volume":"41","author":"A Grimes","year":"2009","unstructured":"Grimes A, Chandra SB. Significance of cellular senescence in aging and cancer. Cancer Res Treat. 2009;41:187. https:\/\/doi.org\/10.4143\/crt.2009.41.4.187.","journal-title":"Cancer Res Treat"},{"key":"4379_CR34","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1097\/MPA.0b013e318258055c","volume":"41","author":"S Egawa","year":"2012","unstructured":"Egawa S, Toma H, Ohigashi H, Okusaka T, Nakao A, Hatori T, et al. Japan Pancreatic Cancer Registry; 30th year anniversary: Japan Pancreas Society. Pancreas. 2012;41:985\u201392. https:\/\/doi.org\/10.1097\/MPA.0b013e318258055c.","journal-title":"Pancreas"},{"key":"4379_CR35","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1470-2045(18)30080-9","volume":"19","author":"X-R Tang","year":"2018","unstructured":"Tang X-R, Li Y-Q, Liang S-B, Jiang W, Liu F, Ge W-X, et al. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study. Lancet Oncol. 2018;19:382\u201393. https:\/\/doi.org\/10.1016\/S1470-2045(18)30080-9.","journal-title":"Lancet Oncol"},{"key":"4379_CR36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-025-02226-9","volume":"24","author":"L Luo","year":"2025","unstructured":"Luo L, Yang P, Mastoraki S, Rao X, Wang Y, Kettner NM, et al. Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4\/6 inhibition in patients with HR+\/HER2- metastatic breast cancer. Mol Cancer. 2025;24:48. https:\/\/doi.org\/10.1186\/s12943-025-02226-9.","journal-title":"Mol Cancer"},{"key":"4379_CR37","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1097\/JS9.0000000000001080","volume":"110","author":"Z Wu","year":"2024","unstructured":"Wu Z, Shang G, Zhang K, Wang W, Fan M, Lin R. A nomogram incorporating treatment data for predicting overall survival in gastroenteropancreatic neuroendocrine tumors: a population-based cohort study. Int J Surg. 2024;110:2178\u201386. https:\/\/doi.org\/10.1097\/JS9.0000000000001080.","journal-title":"Int J Surg"},{"key":"4379_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-020-01370-0","volume":"37","author":"L Yin","year":"2020","unstructured":"Yin L, Xiao L, Gao Y, Wang G, Gao H, Peng Y, et al. Comparative bioinformatical analysis of pancreatic head cancer and pancreatic body\/tail cancer. Med Oncol. 2020;37:46. https:\/\/doi.org\/10.1007\/s12032-020-01370-0.","journal-title":"Med Oncol"},{"key":"4379_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejca.2018.10.008","volume":"106","author":"TM Mackay","year":"2019","unstructured":"Mackay TM, van Erning FN, van der Geest LGM, de Groot JWB, Haj Mohammad N, Lemmens VE, et al. Association between primary origin (head, body and tail) of metastasised pancreatic ductal adenocarcinoma and oncologic outcome: a population-based analysis. Eur J Cancer. 2019;106:99\u2013105. https:\/\/doi.org\/10.1016\/j.ejca.2018.10.008.","journal-title":"Eur J Cancer"},{"key":"4379_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1521616","author":"Y Chen","year":"2025","unstructured":"Chen Y, Liu X, Yu J, Li J, Li J, Yi P, et al. Risk and prognostic factors of survival for patients with pancreatic ductal adenocarcinoma metastasis to lung: a cohort study. Front Oncol. 2025. https:\/\/doi.org\/10.3389\/fonc.2025.1521616.","journal-title":"Front Oncol"},{"key":"4379_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6178-z","volume":"19","author":"W Sheng","year":"2019","unstructured":"Sheng W, Dong M, Wang G, Shi X, Gao W, Wang K, et al. The diversity between curatively resected pancreatic head and body-tail cancers based on the 8th edition of AJCC staging system: a multicenter cohort study. BMC Cancer. 2019;19:981. https:\/\/doi.org\/10.1186\/s12885-019-6178-z.","journal-title":"BMC Cancer"},{"key":"4379_CR42","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.cell.2011.11.060","volume":"148","author":"H Haeno","year":"2012","unstructured":"Haeno H, Gonen M, Davis MB, Herman JM, Iacobuzio-Donahue CA, Michor F. Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell. 2012;148:362\u201375. https:\/\/doi.org\/10.1016\/j.cell.2011.11.060.","journal-title":"Cell"},{"key":"4379_CR43","doi-asserted-by":"publisher","first-page":"153303382096211","DOI":"10.1177\/1533033820962117","volume":"19","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Liu W. Pancreatic cancer: a review of risk factors, diagnosis, and treatment. Technol Cancer Res Treat. 2020;19:1533033820962117. https:\/\/doi.org\/10.1177\/1533033820962117.","journal-title":"Technol Cancer Res Treat"},{"key":"4379_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41571-018-0112-1","volume":"16","author":"O Strobel","year":"2019","unstructured":"Strobel O, Neoptolemos J, J\u00e4ger D, B\u00fcchler MW. Optimizing the outcomes of pancreatic cancer surgery. Nat Rev Clin Oncol. 2019;16:11\u201326. https:\/\/doi.org\/10.1038\/s41571-018-0112-1.","journal-title":"Nat Rev Clin Oncol"},{"key":"4379_CR45","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1097\/MPA.0000000000001872","volume":"50","author":"J Doyle","year":"2021","unstructured":"Doyle J, Amundsen T, Hall JA, Raiyani C, Wong L. Reviewing the outcomes of different treatment approaches in elderly pancreatic cancer patients. Pancreas. 2021;50:1020\u20133. https:\/\/doi.org\/10.1097\/MPA.0000000000001872.","journal-title":"Pancreas"},{"key":"4379_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctrv.2018.10.013","volume":"72","author":"M Macchini","year":"2019","unstructured":"Macchini M, Chiaravalli M, Zanon S, Peretti U, Mazza E, Gianni L, et al. Chemotherapy in elderly patients with pancreatic cancer: efficacy, feasibility and future perspectives. Cancer Treat Rev. 2019;72:1\u20136. https:\/\/doi.org\/10.1016\/j.ctrv.2018.10.013.","journal-title":"Cancer Treat Rev"},{"key":"4379_CR47","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1056\/NEJMc1107627","volume":"365","author":"V Vaccaro","year":"2011","unstructured":"Vaccaro V, Sperduti I, Milella M. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;365:768\u20139. https:\/\/doi.org\/10.1056\/NEJMc1107627.","journal-title":"N Engl J Med"},{"key":"4379_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.752176","volume":"12","author":"W Zhang","year":"2022","unstructured":"Zhang W, Ji L, Wang X, Zhu S, Luo J, Zhang Y, et al. Nomogram predicts risk and prognostic factors for bone metastasis of pancreatic cancer: a population-based analysis. Front Endocrinol. 2022;12:752176. https:\/\/doi.org\/10.3389\/fendo.2021.752176.","journal-title":"Front Endocrinol"},{"key":"4379_CR49","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/01.mpa.0000166998.04266.88","volume":"31","author":"K Shibata","year":"2005","unstructured":"Shibata K, Matsumoto T, Yada K, Sasaki A, Ohta M, Kitano S. Factors predicting recurrence after resection of pancreatic ductal carcinoma. Pancreas. 2005;31:69\u201373. https:\/\/doi.org\/10.1097\/01.mpa.0000166998.04266.88.","journal-title":"Pancreas"},{"key":"4379_CR50","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1097\/MPA.0b013e3181bd5cfa","volume":"39","author":"T Fujita","year":"2010","unstructured":"Fujita T, Nakagohri T, Gotohda N, Takahashi S, Konishi M, Kojima M, et al. Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas. Pancreas. 2010;39:e48-54. https:\/\/doi.org\/10.1097\/MPA.0b013e3181bd5cfa.","journal-title":"Pancreas"},{"key":"4379_CR51","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1002\/bjs.10772","volume":"105","author":"SB Dreyer","year":"2018","unstructured":"Dreyer SB, Jamieson NB, Upstill-Goddard R, Bailey PJ, McKay CJ, Australian Pancreatic Cancer Genome Initiative, et al. Defining the molecular pathology of pancreatic body and tail adenocarcinoma. Br J Surg. 2018;105:e183\u201391. https:\/\/doi.org\/10.1002\/bjs.10772.","journal-title":"Br J Surg"},{"key":"4379_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00571-4","volume":"8","author":"M Abdelrahim","year":"2024","unstructured":"Abdelrahim M, Esmail A, Kasi A, Esnaola NF, Xiu J, Baca Y, et al. Comparative molecular profiling of pancreatic ductal adenocarcinoma of the head versus body and tail. NPJ Precis Oncol. 2024;8:85. https:\/\/doi.org\/10.1038\/s41698-024-00571-4.","journal-title":"NPJ Precis Oncol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-04379-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04379-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04379-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T13:56:55Z","timestamp":1770127015000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-04379-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4379"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-04379-x","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data were obtained from the de-identified SEER database. This secondary analysis of publicly available data was exempt from institutional ethics review and complied with the Declaration of Helsink. The data used in this study are de-identified and publicly available from the SEER database; thus, no individual consent was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable; this study used de-identified data from the SEER database, and no human subjects were directly involved. Therefore, ethics approval and informed consent were not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involved in human and animal participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"227"}}